Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer.
作者信息
Garofalo Michela, Jeon Young-Jun, Nuovo Gerard J, Middleton Justin, Secchiero Paola, Joshi Pooja, Alder Hansjuerg, Nazaryan Natalya, Di Leva Gianpiero, Romano Giulia, Crawford Melissa, Nana-Sinkam Patrick, Croce Carlo M
出版信息
PLoS One. 2015 Jun 25;10(6):e0131729. doi: 10.1371/journal.pone.0131729. eCollection 2015.
Abstract
摘要
相似文献
1
Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer.更正：miR-34a/c依赖性血小板衍生生长因子受体α/β下调抑制肺癌肿瘤发生并增强TRAIL诱导的凋亡
PLoS One. 2015 Jun 25;10(6):e0131729. doi: 10.1371/journal.pone.0131729. eCollection 2015.
2
Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer.更正：miR-34a/c 依赖性血小板衍生生长因子受体α/β下调抑制肺癌发生并增强 TRAIL 诱导的细胞凋亡。
PLoS One. 2022 Apr 20;17(4):e0267628. doi: 10.1371/journal.pone.0267628. eCollection 2022.
3
Luteolin Induces Apoptosis by Up-regulating miR-34a in Human Gastric Cancer Cells.木犀草素通过上调人胃癌细胞中的miR-34a诱导细胞凋亡。
Technol Cancer Res Treat. 2015 Dec;14(6):747-55. doi: 10.7785/tcrt.2012.500434. Epub 2014 Nov 26.
4
Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.二甲双胍诱导微小RNA-34a下调Sirt1/Pgc-1α/Nrf2通路，导致野生型p53癌细胞对氧化应激和治疗药物的敏感性增加。
Free Radic Biol Med. 2014 Sep;74:21-34. doi: 10.1016/j.freeradbiomed.2014.06.010. Epub 2014 Jun 24.
5
Down-regulation of microRNA-34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance.类风湿性关节炎滑膜成纤维细胞中微小RNA - 34a*的下调促进抗凋亡。
Arthritis Rheum. 2012 Jun;64(6):1771-9. doi: 10.1002/art.34334. Epub 2011 Dec 12.
6
Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer.甲基化诱导的miR-34a沉默通过AMPK/mTOR途径直接上调ATG4B诱导的自噬增强前列腺癌的化疗耐药性。
Oncol Rep. 2016 Jan;35(1):64-72. doi: 10.3892/or.2015.4331. Epub 2015 Oct 16.
7
MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells.微小RNA-34a通过调控人SW480细胞中的沉默信息调节因子1/p53信号通路来抑制细胞迁移和侵袭。
Mol Med Rep. 2015 May;11(5):3301-7. doi: 10.3892/mmr.2015.3182. Epub 2015 Jan 12.
8
microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.miRNA-34a 可使肺癌细胞系对 DDP 治疗敏感，而与 p53 状态无关。
Cancer Biother Radiopharm. 2013 Feb;28(1):45-50. doi: 10.1089/cbr.2012.1218. Epub 2012 Oct 4.
9
Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.壳聚糖纳米颗粒介导的miRNA-34a递送可降低前列腺肿瘤在骨中的生长，并且其表达可诱导非经典自噬。
Oncotarget. 2015 Oct 6;6(30):29161-77. doi: 10.18632/oncotarget.4971.
10
Is miR-34a a Well-equipped Swordsman to Conquer Temple of Molecular Oncology?miR-34a是征服分子肿瘤学殿堂的装备精良的剑客吗？
Chem Biol Drug Des. 2016 Mar;87(3):321-34. doi: 10.1111/cbdd.12634. Epub 2016 Jan 13.
引用本文的文献
1
Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer.更正：miR-34a/c 依赖性血小板衍生生长因子受体α/β下调抑制肺癌发生并增强 TRAIL 诱导的细胞凋亡。
PLoS One. 2022 Apr 20;17(4):e0267628. doi: 10.1371/journal.pone.0267628. eCollection 2022.
2
microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistance.靶向细胞胆固醇的微小RNA：对抗抗癌药物耐药性的意义
Genes Cancer. 2020;11(1-2):20-42. doi: 10.18632/genesandcancer.202.
3
Research progress on the relationship between lung cancer drug-resistance and microRNAs.肺癌耐药与微小RNA关系的研究进展
J Cancer. 2019 Nov 17;10(27):6865-6875. doi: 10.7150/jca.31952. eCollection 2019.
4
MicroRNAs Mediated Regulation of Expression of Nucleoside Analog Pathway Genes in Acute Myeloid Leukemia.微小 RNA 介导的核苷酸类似物途径基因在急性髓细胞白血病中的表达调控。
Genes (Basel). 2019 Apr 24;10(4):319. doi: 10.3390/genes10040319.
5
inhibits growth and promotes apoptosis of osteosarcoma in nude mice through targetly regulating TGIF2 expression.通过靶向调控 TGIF2 表达，抑制裸鼠骨肉瘤的生长并促进其凋亡。
Biosci Rep. 2018 Jun 12;38(3). doi: 10.1042/BSR20180078. Print 2018 Jun 29.
6
MiR-187 overexpression inhibits cervical cancer progression by targeting HPV16 E6.MiR-187过表达通过靶向HPV16 E6抑制宫颈癌进展。
Oncotarget. 2017 Apr 29;8(38):62914-62926. doi: 10.18632/oncotarget.17516. eCollection 2017 Sep 8.
7
MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer.微小RNA-34a和微小RNA-206作为宫颈癌新的预后和治疗生物标志物。
Cancer Cell Int. 2017 Jun 9;17:63. doi: 10.1186/s12935-017-0431-9. eCollection 2017.
8
miR-34a regulates HDAC1 expression to affect the proliferation and apoptosis of hepatocellular carcinoma.微小RNA-34a通过调节组蛋白去乙酰化酶1的表达来影响肝细胞癌的增殖和凋亡。
Am J Transl Res. 2017 Jan 15;9(1):103-114. eCollection 2017.
本文引用的文献
1
MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer.微小RNA-34a/c依赖性血小板衍生生长因子受体-α/β下调抑制肺癌肿瘤发生并增强肿瘤坏死因子相关凋亡诱导配体诱导的细胞凋亡
PLoS One. 2013 Jun 21;8(6):e67581. doi: 10.1371/journal.pone.0067581. Print 2013.
Zotero 插件